Condition: Infection, Intraabdominal · Sepsis Abdominal · Biomarker · Sponsor: Azienda Ospedaliero, Universitaria Pisana
To early evaluate the serum levels of calprotectin in patients suffering from intra-abdominal sepsis requiring a surgical treatment. The research project aims to investigate the role of serum calprotectin in the diagnosis of sepsis and to establish whether its level significantly correlates with different degree of disease severity and with short and long-term outcomes. If these associations were confirmed, serum calprotectin would represent an easily and rapidly detectable biomarker able to predict the severity of sepsis.
This description comes directly from the study's public registry record.
SIlvia Strambi, MD · +393334905867 · silvia.strambi@phd.unipi.it
Laura Caponi, MD · +393287852635 · laura.caponi@unipi.it
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero Universitaria Pisana (AOUP) | Pisa, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06614088